Evercore Cuts Intuitive Surgical (NASDAQ:ISRG) Price Target to $480.00

Intuitive Surgical (NASDAQ:ISRG) had its price objective cut by Evercore from $550.00 to $480.00 in a report issued on Monday morning,MarketScreener reports. They currently have a neutral rating on the medical equipment provider’s stock.

Other research analysts have also issued reports about the stock. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research note on Wednesday, March 11th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Raymond James Financial boosted their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Sanford C. Bernstein upped their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Finally, Robert W. Baird lowered their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research report on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $607.00.

Intuitive Surgical Stock Up 2.1%

Shares of Intuitive Surgical stock opened at $462.28 on Monday. Intuitive Surgical has a 52-week low of $427.84 and a 52-week high of $603.88. The company’s 50-day simple moving average is $483.27 and its 200-day simple moving average is $514.06. The firm has a market cap of $164.17 billion, a price-to-earnings ratio of 58.59, a price-to-earnings-growth ratio of 3.49 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the previous year, the business posted $2.21 earnings per share. The business’s revenue was up 18.8% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 32,943 shares of company stock worth $17,279,568 over the last ninety days. 0.60% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of the business. J. Derek Lewis & Associates Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $2,963,000. Purpose Unlimited Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $291,000. Carter Financial LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $204,000. Osbon Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $148,000. Finally, World Investment Advisors lifted its stake in shares of Intuitive Surgical by 27.6% during the fourth quarter. World Investment Advisors now owns 6,888 shares of the medical equipment provider’s stock valued at $3,901,000 after buying an additional 1,489 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive’s push to embed AI into its da Vinci systems reinforces the company’s long‑term growth and margin story, supporting investor confidence in recurring procedure growth and software monetization. AI Push Article
• Positive Sentiment: Goldman Sachs kept a Buy rating on ISRG, signaling continued institutional support despite lowering its price target to $609 — the maintained Buy reduces downside risk for some investors. Goldman Sachs PT Article
• Positive Sentiment: Third‑party coverage highlights Intuitive’s strong balance sheet (no debt) and near‑monopoly position in robotic surgery — a supportive fundamental narrative for long‑term investors. Fool No‑Debt Article
• Positive Sentiment: Analysts and commentators point to an underappreciated large opportunity in anti‑obesity procedures that could widen Intuitive’s TAM and future procedure volumes. Anti‑Obesity Opportunity Article
• Neutral Sentiment: Market summaries note ISRG rose today but underperformed the market, suggesting selective buying rather than broad momentum. Zacks Market Summary
• Neutral Sentiment: Erste Group trimmed FY2027 EPS estimates very slightly (from $9.54 to $9.52) — the change is immaterial to near‑term outlook but reflects close monitoring of margins and procedure growth.
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG, introducing downside bias from a well‑known sell‑side voice that can influence short‑term flows and sentiment. Evercore Forecast Article
• Negative Sentiment: Goldman’s sizable cut to its price target (from $714 to $609) signals valuation pressure — even with a Buy rating, lower targets can prompt profit‑taking or cap repositioning by funds. Goldman Sachs PT Article

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.